Market Overview:
The global extracorporeal membrane oxygenation (ECMO) market is expected to register a CAGR of 7.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing incidence of respiratory and cardiac diseases, rising geriatric population, and technological advancements in ECMO devices. Based on type, the veno-arterial segment is expected to account for the largest share of the global ECMO market in 2018. This segment is also projected to grow at a higher CAGR during the forecast period as compared to other segments. The large share and high growth rate of this segment can be attributed to factors such as increasing incidence of respiratory diseases and technological advancements in ECMO devices. Based on application, respiratory applications are estimated to account for majority share of the global ECMO market in 2018 followed by cardiac applications. However, cardiac applications are projected grow at a higher CAGR than respiratory applications duringthe forecast period owingto increase incidencesof heart failures across globe .
 Industry Outlook.svg)
Product Definition:
Extracorporeal Membrane Oxygenation (ECMO) is a technique used to provide oxygen and carbon dioxide removal from the blood outside of the body. ECMO is used as a life-saving measure in patients with severe respiratory or cardiac failure.
Veno-Arterial:
Veno-arterial ECMO (VA-ECMO) is a technique used to supply oxygen and blood flow by means of a venous circuit. The circuit starts with the patient’s arteriovenous graft which may be internal or external, the source of the blood does not matter as long as it is warm.
Arterio-Venous:
Arterio-venous (AV) is a technique used to provide venous return and arterial inflow simultaneously. It is an important component of extracorporeal membrane oxygenation (ECMO) as it helps in the delivery of blood flow outside the organelles where it cannot be supplied by central venous pressure.
In this procedure, a catheter is inserted into either arm or leg.
Application Insights:
Based on application, the global market is segmented into respiratory, cardiac and extracorporeal cardiopulmonary resuscitation (ECPR). The respiratory segment dominated the overall market in terms of revenue in 2017. This can be attributed to growing awareness about ECMO procedures and increasing incidence of respiratory disorders. According to data published by ELSO, an estimated 1,000-1,500 patients undergo ECMO therapy annually for lung failure across the globe.
The cardiac surgery segment is expected to witness lucrative growth over the forecast period due to rising number of cardiovascular surgeries being performed worldwide. According to WHO statistics published in 2018, around 1 in every 3 deaths occur due to CVDs globally which indicates a huge potential customer base for these devices worldwide. Moreover, various public and private organizations are taking initiatives such as Cardiac Surgery Education Program (SEEP) that trains surgeons from developing countries howto perform better during heart surgeries thus driving demand further over the forecast period.
Regional Analysis:
Europe dominated the global market in 2017 owing to the availability of well-developed healthcare infrastructure, high patient awareness, and presence of highly skilled and experienced physicians. In addition, a large number of clinical studies on EVAO are being conducted in Europe which is further boosting the regional market growth.
Asia Pacific is expected to witness lucrative growth over the forecast period due to rising disposable income coupled with increasing prevalence of chronic respiratory diseases such as COPD and asthma among others. Moreover, an increase in demand for ECMO from developing countries such as India & China & South Korea can also be attributed for regional market growth during the forecast period.
Growth Factors:
- Increasing incidence of respiratory diseases: The increasing incidence of respiratory diseases is one of the major growth drivers for the ECMO market. Respiratory diseases are a leading cause of death and disability worldwide, and their incidence is expected to increase in the future due to factors such as population growth, aging, and air pollution. This will create a high demand for ECMO devices and services, which will drive the growth of the ECMO market.
- Technological advancements: The technological advancements in ECMO devices are another major driver for the market’s growth. These advancements have led to increased efficiency and safety of these devices, which has resulted in their growing adoption by hospitals worldwide. This is likely to continue in the future, driving market growth further.
- Rising number of organ transplants: The rising number of organ transplants is another key factor that is driving demand for ECMO devices and services globally. With an increasing number of patients requiring life-saving organ transplants each year, hospitals are increasingly adopting ECMO technology as a means to improve patient outcomes after surgery transplantation procedures .This trend is likely to continue in coming years, propelling market growth further..
Scope Of The Report
Report Attributes
Report Details
Report Title
Extracorporeal Membrane Oxygenation (ECMO) Market Research Report
By Type
Veno-Arterial, Arterio-Venous, Veno-Venous
By Application
Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)
By Companies
MAQUET, Microport, XENIOS, LivaNova, Medtronic, Terumo Cardiovascular, Nipro
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
122
Number of Tables & Figures
86
Customization Available
Yes, the report can be customized as per your need.
Global Extracorporeal Membrane Oxygenation (ECMO) Market Report Segments:
The global Extracorporeal Membrane Oxygenation (ECMO) market is segmented on the basis of:
Types
Veno-Arterial, Arterio-Venous, Veno-Venous
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- MAQUET
- Microport
- XENIOS
- LivaNova
- Medtronic
- Terumo Cardiovascular
- Nipro
 Market Overview.svg)
Highlights of The Extracorporeal Membrane Oxygenation (ECMO) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Veno-Arterial
- Arterio-Venous
- Veno-Venous
- By Application:
- Respiratory
- Cardiac
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Extracorporeal Membrane Oxygenation (ECMO) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Extracorporeal membrane oxygenation (ECMO) is a life-saving procedure that uses an artificial air supply to provide supplemental oxygen to patients with respiratory failure. ECMO is most commonly used in infants, children, and adults who have suffered a heart attack or stroke and cannot breathe on their own.
Some of the key players operating in the extracorporeal membrane oxygenation (ecmo) market are MAQUET, Microport, XENIOS, LivaNova, Medtronic, Terumo Cardiovascular, Nipro.
The extracorporeal membrane oxygenation (ecmo) market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Extracorporeal Membrane Oxygenation (ECMO) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Extracorporeal Membrane Oxygenation (ECMO) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Extracorporeal Membrane Oxygenation (ECMO) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Extracorporeal Membrane Oxygenation (ECMO) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size & Forecast, 2020-2028
4.5.1 Extracorporeal Membrane Oxygenation (ECMO) Market Size and Y-o-Y Growth
4.5.2 Extracorporeal Membrane Oxygenation (ECMO) Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Veno-Arterial
5.2.2 Arterio-Venous
5.2.3 Veno-Venous
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Respiratory
6.2.2 Cardiac
6.2.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Extracorporeal Membrane Oxygenation (ECMO) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Extracorporeal Membrane Oxygenation (ECMO) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Veno-Arterial
9.6.2 Arterio-Venous
9.6.3 Veno-Venous
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Respiratory
9.10.2 Cardiac
9.10.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Veno-Arterial
10.6.2 Arterio-Venous
10.6.3 Veno-Venous
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Respiratory
10.10.2 Cardiac
10.10.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Veno-Arterial
11.6.2 Arterio-Venous
11.6.3 Veno-Venous
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Respiratory
11.10.2 Cardiac
11.10.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Veno-Arterial
12.6.2 Arterio-Venous
12.6.3 Veno-Venous
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Respiratory
12.10.2 Cardiac
12.10.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Veno-Arterial
13.6.2 Arterio-Venous
13.6.3 Veno-Venous
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Respiratory
13.10.2 Cardiac
13.10.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Extracorporeal Membrane Oxygenation (ECMO) Market: Competitive Dashboard
14.2 Global Extracorporeal Membrane Oxygenation (ECMO) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 MAQUET
14.3.2 Microport
14.3.3 XENIOS
14.3.4 LivaNova
14.3.5 Medtronic
14.3.6 Terumo Cardiovascular
14.3.7 Nipro
